Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID-repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages

被引:60
作者
Briquet, Alexandra [1 ]
Dubois, Sophie [1 ]
Bekaert, Sandrine [1 ]
Dolhet, Marie [1 ]
Beguin, Yves [1 ]
Gothot, Andre [1 ]
机构
[1] Univ Liege, Hematol Unit, GIGA Res, B-4000 Liege, Belgium
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷 / 01期
关键词
human bone marrow mesenchymal stem cells; NOD/SCID-repopulating cells; progenitor cells of B lymphoid; HEMATOPOIETIC STEM/PROGENITOR CELLS; UMBILICAL-CORD BLOOD; STROMAL CELLS; CD34(+) CELLS; MICE; COTRANSPLANTATION; MICROENVIRONMENT; RECONSTITUTION; LYMPHOCYTES; ENGRAFTMENT;
D O I
10.3324/haematol.2009.008524
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Bone marrow mesenchymal stem cells support proliferation and differentiation of hematopoietic progenitor cells in vitro. Since these cells constitute a rare subset of bone marrow cells, mesenchymal stem cell preparations for clinical purposes require a preparative step of ex vivo multiplication. The aim of our study was to analyze the influence of culture duration on mesenchymal stem cell supportive activity. Design and Methods Mesenchymal stem cells were expanded for up to ten passages. These cells and CD34+ cells were seeded in cytokine-free co-cultures after which the phenotype, clonogenic capacity and in vivo repopulating activity of harvested hematopoietic cells were assessed. Results Early passage mesenchymal stem cells supported hematopoietic progenitor cell expansion and differentiation toward both B lymphoid and myeloid lineages. Late passage mesenchymal stem cells did not support hematopoietic progenitor cell and myeloid cell outgrowth but maintained B-cell supportive ability. In vitro maintenance of NOD/SCID mouse repopulating cells cultured for 1 week in contact with mesenchymal stem cells was effective until the fourth passage of the mesenchymal cells and declined thereafter. The levels of engraftment of CD34+ cells in NOD/SCID mice was higher when these cells were co-injected with early passage mesenchymal stem cells; however mesenchymal cells expanded beyond nine passages were ineffective in promoting CD34+ cell engraftment. Non-contact cultures indicated that mesenchymal stem cell supportive activity involved diffusible factors. Among these, interleukins 6 and 8 contributed to the supportive activity of early passage mesenchymal stem cells but not to those of late passage cells. The phenotype, as well as fat, bone and cartilage differentiation capacity, of mesenchymal stem cells did not change during their culture. Conclusions Extended culture of mesenchymal stem cells alters the ability of these cells to support hematopoietic progenitor cells without causing concomitant changes in their phenotype or differentiation capacity.
引用
收藏
页码:47 / 56
页数:10
相关论文
共 26 条
[1]   Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice [J].
Angelopoulou, M ;
Novelli, E ;
Grove, JE ;
Rinder, HM ;
Civin, C ;
Cheng, LZ ;
Krause, DS .
EXPERIMENTAL HEMATOLOGY, 2003, 31 (05) :413-420
[2]   Individual CD34(+)CD38(low)CD19(-)CD10(-) progenitor cells from human cord blood generate B lymphocytes and granulocytes [J].
Berardi, AC ;
Meffre, E ;
Pflumio, F ;
Katz, A ;
Vainchenker, W ;
Schiff, C ;
Coulombel, L .
BLOOD, 1997, 89 (10) :3554-3564
[3]   Enhanced in vivo homing of uncultured and selectively amplified cord blood CD34+ cells by cotransplantation with cord blood-derived unrestricted somatic stem cells [J].
Chan, Shing Leng ;
Choi, Michael ;
Wnendt, Stephan ;
Kraus, Morey ;
Teng, Eileen ;
Leong, Hwei Fen ;
Merchav, Shosh .
STEM CELLS, 2007, 25 (02) :529-536
[4]   A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells [J].
da Silva, CL ;
Gonçalves, R ;
Crapnell, KB ;
Cabral, JMS ;
Zanjani, ED ;
Almeida-Porada, G .
EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) :828-835
[5]   Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[6]   Co-culture of cord blood CD34+ cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice [J].
Fei, X. M. ;
Wu, Y. J. ;
Chang, Z. ;
Miao, K. R. ;
Tang, Y. H. ;
Zhou, X. Y. ;
Wang, L. X. ;
Pan, Q. Q. ;
Wang, C. Y. .
CYTOTHERAPY, 2007, 9 (04) :338-347
[7]  
Fluckiger AC, 1998, BLOOD, V92, P4509
[8]   SSEA-4 identifies mesenchymal stem cells from bone marrow [J].
Gang, Eun J. ;
Bosnakovski, Darko ;
Figueiredo, Camila A. ;
Visser, Jan W. ;
Perlingeiro, Rita C. R. .
BLOOD, 2007, 109 (04) :1743-1751
[9]   Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow [J].
Gronthos, S ;
Zannettino, ACW ;
Hay, SJ ;
Shi, ST ;
Graves, SE ;
Kortesidis, A ;
Simmons, PJ .
JOURNAL OF CELL SCIENCE, 2003, 116 (09) :1827-1835
[10]   Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood [J].
Huang, Guo-Ping ;
Pan, Zhi-Jun ;
Jia, Bing-Bing ;
Zheng, Qiang ;
Xie, Chun-Gang ;
Gu, Jiang-Hong ;
McNiece, Ian K. ;
Wang, Jin-Fu .
CELL TRANSPLANTATION, 2007, 16 (06) :579-585